Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001383477 | SCV001582628 | pathogenic | Epilepsy, childhood absence 2; Febrile seizures, familial, 8 | 2022-02-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys144Glufs*16) in the GABRG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GABRG2 are known to be pathogenic (PMID: 22539854, 22750526, 24407264). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1071103). This variant has not been reported in the literature in individuals affected with GABRG2-related conditions. |